Cronos Group Inc.

TSX:CRON.TO

Drug Manufacturers - Specialty & Generic

Healthcare
$4.57 -0.27%

-$0.01 today

Market cap
$1.67B
Beta
1.25
P/E (TTM)
-488.1
EPS (TTM)
-$0.01
52W Low $2.54High $4.66

Volume 0.15M

Average 0.19M

CRON.TO EPS (Diluted)

Earnings per share assuming conversion of dilutive securities such as options and convertible instruments.

Cronos Group Inc.TSX: CRON.TO

EPS (Diluted) · Q1 FY2026 · quarter ended Mar 2026

EPS (Diluted) growth accelerates

Q1 FY2026 EPS (Diluted) of $0.04 rose 77.0% year over year, ahead of the -101.9% change in trailing-twelve-month EPS (Diluted).

Context

  • EPS (Diluted) increased in 2 of the last 3 fiscal years.

What to watch

Whether EPS (Diluted) reaches the consensus estimate from 5 analysts of $0.18 (+833.9%) for the fiscal year ending Dec 2026, a step up from the -125.1% reported in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
$0.04+837.5% QoQ
Last fiscal yearDec 2025
-$0.03-125.1% YoY
LTMMar 2026
-$0-101.9% YoY
EPS (Diluted) past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+77.0%+110.0%+33.0 pp
1 year-125.1%+833.9%+959.0 pp
3-year CAGR———
5-year CAGR——
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EPS (Diluted) history

USD · from the income statement

Latest · FY2025
(0.03) USD
Year-over-year change
-125.1%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

EPS (Diluted) vs competitors

How CRON.TO compares with its peers on the latest reported figures

  • Peers report in different currencies, so EPS (Diluted) is compared through growth and rates rather than absolute size.
  • Its year-over-year change of -101.9% is the lowest of 6, against a peer median of +13.7%.
CRON.TO Competitors
EPS (Diluted) for CRON.TO and competitors
Company Period LTM YoY 3-year CAGR
EXE.TOExtendicare Inc.LTM Jun 2026CA$1.31 CAD+28.4%+9.3%
SIA.TOSienna Senior Living Inc.LTM Sep 2026CA$0.5 CAD+13.7%+48.4%
WELL.TOWELL Health Technologies Corp.LTM Mar 2026CA$0.11 CAD+179.0%—
GUD.TOKnight Therapeutics Inc.LTM Mar 2026CA$0.05 CAD-54.8%—
CRON.TOCronos Group Inc.LTM Mar 2026-$0 USD-101.9%—
TLRY.TOTilray Brands, Inc.LTM Feb 2026-$14.81 USD-40.4%—
Peer median (excluding CRON.TO) —+13.7%+28.8%

Competitors are the stored peer set for CRON.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue64.02M87.54M87.03M117.5M149.15M
Cost of Revenue81.47M71.96M75.15M87.05M87.45M
Gross Profit(17.45M)15.58M11.88M30.45M61.7M
Gross Margin-27.3%17.8%13.7%25.9%41.4%
Research & Development21.66M13.25M5.83M4.22M4.53M
Selling, General & Admin120.67M101.64M80.74M76.74M75.01M
Operating Expenses272.09M128.01M96.48M106.91M79.54M
Depreciation & Amortization13.36M11.52M7.44M8.84M14.48M
EBITDA(150.79M)(93.81M)(72.28M)(45.37M)(2.94M)
EBITDA Margin-235.5%-107.2%-83.0%-38.6%-2.0%
Operating Income(289.54M)(112.44M)(84.6M)(76.46M)(17.84M)
Operating Margin-452.2%-128.4%-97.2%-65.1%-12.0%
Interest Income8.92M21.84M52.07M49.52M40.66M
Interest Expense00000
Other Income / Expenses162.1M(9.66M)11.1M113.01M419.21K
Income Before Tax(127.44M)(122.1M)(73.49M)36.55M(17.42M)
Pre-Tax Margin-199.1%-139.5%-84.4%31.1%-11.7%
Income Tax Expense(427.41K)34.48M(3.23M)(3.44M)(14.44M)
Net Income(392.81M)(170.26M)(73.79M)41.04M(9.61M)
Net Margin-613.5%-194.5%-84.8%34.9%-6.4%
EPS (Basic)(0.34)(0.42)(0.18)0.10(0.03)
EPS (Diluted)(0.34)(0.42)(0.18)0.10(0.03)
Weighted Avg Shares369.73M370.39M380.96M382.16M383.47M
Weighted Avg Shares (Diluted)370.39M370.39M380.96M382.16M383.47M

Cronos Group Inc.

TSX:CRON.TO

Intrinsic Alpha fair value

Locked

Current Price

$4.57

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.